| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $726.4M | +3.6% |
| Cost of Revenue | $149.7M | -12.1% |
| R&D Expense | $117.3M | +43.8% |
| SG&A Expense | $368.8M | +25.4% |
| Operating Income | $19.2M | +126.2% |
| Interest Expense | $17.4M | +5.3% |
| Pre-tax Income | $16.9M | +126.7% |
| Income Tax | $9.8M | -73.0% |
| Net Income | $7.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $158.5M | -42.7% |
| Short-term Investments | $79.9M | -61.6% |
| Accounts Receivable | $124.1M | +9.5% |
| Inventory | $152.9M | +22.0% |
| Current Assets | $548.0M | -26.5% |
| Total Assets | $1.26B | -18.6% |
| Current Liabilities | $120.6M | -61.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $152.0M | -19.7% |
| Capital Expenditures | $15.3M | +44.2% |
| Investing Cash Flow | $99.5M | +219.5% |
| Financing Cash Flow | -$369.6M | -2228.8% |
| Free Cash Flow | $136.7M | -23.5% |
| +107.1% |
| EPS (Basic) | $0.16 | +107.4% |
| EPS (Diluted) | $0.16 | +107.4% |
| Long-term Debt |
| $372.2M |
| -36.4% |
| Total Liabilities | $571.8M | -26.2% |
| Stockholders' Equity | $693.1M | -11.0% |